nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—COMT—Parkinson's disease	0.833	1	CbGaD
Dobutamine—COMT—telencephalic ventricle—Parkinson's disease	0.00455	0.158	CbGeAlD
Dobutamine—Masoprocol—IGF1R—Parkinson's disease	0.00249	0.277	CrCbGaD
Dobutamine—Dopamine—DBH—Parkinson's disease	0.00161	0.178	CrCbGaD
Dobutamine—CA2—hindbrain—Parkinson's disease	0.00133	0.0464	CbGeAlD
Dobutamine—COMT—brainstem—Parkinson's disease	0.00123	0.0428	CbGeAlD
Dobutamine—COMT—forebrain—Parkinson's disease	0.00119	0.0413	CbGeAlD
Dobutamine—CA5B—cardiovascular system—Parkinson's disease	0.00109	0.0379	CbGeAlD
Dobutamine—ADRB1—forebrain—Parkinson's disease	0.00101	0.035	CbGeAlD
Dobutamine—COMT—cardiovascular system—Parkinson's disease	0.001	0.0349	CbGeAlD
Dobutamine—COMT—medulla oblongata—Parkinson's disease	0.000858	0.0298	CbGeAlD
Dobutamine—ADRB1—cardiovascular system—Parkinson's disease	0.00085	0.0296	CbGeAlD
Dobutamine—CA2—embryo—Parkinson's disease	0.000834	0.029	CbGeAlD
Dobutamine—COMT—midbrain—Parkinson's disease	0.000784	0.0273	CbGeAlD
Dobutamine—COMT—spinal cord—Parkinson's disease	0.000765	0.0266	CbGeAlD
Dobutamine—CA2—brainstem—Parkinson's disease	0.000764	0.0266	CbGeAlD
Dobutamine—CA5B—head—Parkinson's disease	0.000738	0.0257	CbGeAlD
Dobutamine—CA2—forebrain—Parkinson's disease	0.000738	0.0257	CbGeAlD
Dobutamine—CA5B—nervous system—Parkinson's disease	0.0007	0.0243	CbGeAlD
Dobutamine—COMT—head—Parkinson's disease	0.00068	0.0236	CbGeAlD
Dobutamine—CA5B—central nervous system—Parkinson's disease	0.000674	0.0234	CbGeAlD
Dobutamine—COMT—nervous system—Parkinson's disease	0.000644	0.0224	CbGeAlD
Dobutamine—CA2—cardiovascular system—Parkinson's disease	0.000624	0.0217	CbGeAlD
Dobutamine—COMT—central nervous system—Parkinson's disease	0.00062	0.0216	CbGeAlD
Dobutamine—COMT—cerebellum—Parkinson's disease	0.000606	0.0211	CbGeAlD
Dobutamine—Dopamine—MAOB—Parkinson's disease	0.000585	0.065	CrCbGaD
Dobutamine—ADRB1—head—Parkinson's disease	0.000576	0.02	CbGeAlD
Dobutamine—ADRB1—nervous system—Parkinson's disease	0.000546	0.019	CbGeAlD
Dobutamine—Dopamine—COMT—Parkinson's disease	0.000544	0.0604	CrCbGaD
Dobutamine—CA5B—brain—Parkinson's disease	0.000535	0.0186	CbGeAlD
Dobutamine—CA2—medulla oblongata—Parkinson's disease	0.000533	0.0185	CbGeAlD
Dobutamine—ADRB1—central nervous system—Parkinson's disease	0.000526	0.0183	CbGeAlD
Dobutamine—COMT—brain—Parkinson's disease	0.000493	0.0171	CbGeAlD
Dobutamine—CA2—midbrain—Parkinson's disease	0.000487	0.0169	CbGeAlD
Dobutamine—CA2—spinal cord—Parkinson's disease	0.000475	0.0165	CbGeAlD
Dobutamine—CA2—head—Parkinson's disease	0.000422	0.0147	CbGeAlD
Dobutamine—ADRB1—brain—Parkinson's disease	0.000417	0.0145	CbGeAlD
Dobutamine—Dopamine—MAOA—Parkinson's disease	0.00041	0.0456	CrCbGaD
Dobutamine—Dopamine—HTR7—Parkinson's disease	0.000404	0.0449	CrCbGaD
Dobutamine—Formoterol—CYP2D6—Parkinson's disease	0.000401	0.0446	CrCbGaD
Dobutamine—Arformoterol—CYP2D6—Parkinson's disease	0.000401	0.0446	CrCbGaD
Dobutamine—CA2—nervous system—Parkinson's disease	0.0004	0.0139	CbGeAlD
Dobutamine—CA2—central nervous system—Parkinson's disease	0.000385	0.0134	CbGeAlD
Dobutamine—Dopamine—DRD3—Parkinson's disease	0.00038	0.0422	CrCbGaD
Dobutamine—CA2—cerebellum—Parkinson's disease	0.000377	0.0131	CbGeAlD
Dobutamine—Dopamine—DRD1—Parkinson's disease	0.000373	0.0414	CrCbGaD
Dobutamine—Dopamine—SLC6A3—Parkinson's disease	0.000353	0.0393	CrCbGaD
Dobutamine—Dopamine—HTR1A—Parkinson's disease	0.00031	0.0344	CrCbGaD
Dobutamine—CA2—brain—Parkinson's disease	0.000306	0.0106	CbGeAlD
Dobutamine—Labetalol—CYP2D6—Parkinson's disease	0.000293	0.0326	CrCbGaD
Dobutamine—Dopamine—DRD2—Parkinson's disease	0.000263	0.0292	CrCbGaD
Dobutamine—Dopamine—CYP2D6—Parkinson's disease	0.000186	0.0206	CrCbGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000127	0.000978	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000126	0.000975	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000124	0.000954	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—GRM5—Parkinson's disease	0.000123	0.000946	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—GRM5—Parkinson's disease	0.00012	0.000925	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000119	0.000916	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000117	0.000905	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000117	0.000905	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000117	0.000902	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000116	0.000896	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DGKQ—Parkinson's disease	0.000115	0.000886	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GPR37—Parkinson's disease	0.000115	0.000886	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000115	0.000885	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000115	0.000885	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000115	0.000885	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000114	0.000883	CbGpPWpGaD
Dobutamine—CA2—Metabolism—DDC—Parkinson's disease	0.000114	0.000881	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DGKQ—Parkinson's disease	0.000112	0.000866	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GPR37—Parkinson's disease	0.000112	0.000866	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000112	0.000866	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000111	0.000857	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000109	0.000838	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYP2D6—Parkinson's disease	0.000108	0.000834	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTA4—Parkinson's disease	0.000108	0.000832	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CTGF—Parkinson's disease	0.000106	0.000819	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000105	0.00081	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000104	0.000804	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000103	0.000792	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000102	0.000787	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYP2D6—Parkinson's disease	0.000101	0.000779	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.0001	0.000775	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.0001	0.000775	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CTGF—Parkinson's disease	9.91e-05	0.000764	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYP2E1—Parkinson's disease	9.89e-05	0.000763	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	9.83e-05	0.000758	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	9.83e-05	0.000758	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—NQO1—Parkinson's disease	9.78e-05	0.000754	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PLA2G6—Parkinson's disease	9.72e-05	0.00075	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—TH—Parkinson's disease	9.64e-05	0.000743	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MAOB—Parkinson's disease	9.62e-05	0.000742	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GRK5—Parkinson's disease	9.58e-05	0.000739	CbGpPWpGaD
Dobutamine—COMT—Metabolism—DDC—Parkinson's disease	9.58e-05	0.000739	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	9.37e-05	0.000723	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CYCS—Parkinson's disease	9.25e-05	0.000714	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYP2E1—Parkinson's disease	9.23e-05	0.000712	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—NQO1—Parkinson's disease	9.13e-05	0.000704	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—HTR1A—Parkinson's disease	9.05e-05	0.000698	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTA4—Parkinson's disease	9.04e-05	0.000698	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—TH—Parkinson's disease	9e-05	0.000694	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—TAC1—Parkinson's disease	8.91e-05	0.000687	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	8.85e-05	0.000682	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD1—Parkinson's disease	8.74e-05	0.000674	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	8.71e-05	0.000672	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GRK5—Parkinson's disease	8.7e-05	0.000671	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CYCS—Parkinson's disease	8.64e-05	0.000666	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GRM4—Parkinson's disease	8.6e-05	0.000663	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	8.55e-05	0.000659	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	8.51e-05	0.000657	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD3—Parkinson's disease	8.46e-05	0.000653	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	8.41e-05	0.000649	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	8.28e-05	0.000638	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	8.21e-05	0.000634	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—COMT—Parkinson's disease	8.19e-05	0.000632	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	8.19e-05	0.000631	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GSTP1—Parkinson's disease	8.16e-05	0.000629	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	8.15e-05	0.000628	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PLA2G6—Parkinson's disease	8.14e-05	0.000628	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—MAOA—Parkinson's disease	8.14e-05	0.000628	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MAOB—Parkinson's disease	8.06e-05	0.000622	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	8.04e-05	0.00062	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—HMOX1—Parkinson's disease	8.04e-05	0.00062	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	8.03e-05	0.00062	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	8.01e-05	0.000618	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	7.97e-05	0.000615	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	7.87e-05	0.000607	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	7.81e-05	0.000602	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ABCB1—Parkinson's disease	7.72e-05	0.000595	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	7.65e-05	0.00059	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	7.65e-05	0.00059	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—COMT—Parkinson's disease	7.65e-05	0.00059	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	7.64e-05	0.000589	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GSTP1—Parkinson's disease	7.61e-05	0.000587	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—MAOA—Parkinson's disease	7.6e-05	0.000586	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—HMOX1—Parkinson's disease	7.51e-05	0.000579	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GSTM1—Parkinson's disease	7.49e-05	0.000578	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	7.48e-05	0.000577	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	7.48e-05	0.000577	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	7.45e-05	0.000575	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	7.4e-05	0.000571	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	7.29e-05	0.000562	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	7.24e-05	0.000558	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ABCB1—Parkinson's disease	7.21e-05	0.000556	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—GPX1—Parkinson's disease	7.18e-05	0.000554	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP2D6—Parkinson's disease	7.15e-05	0.000551	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	7.04e-05	0.000543	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CTGF—Parkinson's disease	7.02e-05	0.000541	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GSTM1—Parkinson's disease	7e-05	0.00054	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	6.93e-05	0.000534	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	6.88e-05	0.000531	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	6.78e-05	0.000523	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	6.78e-05	0.000523	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	6.78e-05	0.000523	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	6.77e-05	0.000522	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—GPX1—Parkinson's disease	6.7e-05	0.000517	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	6.64e-05	0.000512	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	6.64e-05	0.000512	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—MTHFR—Parkinson's disease	6.62e-05	0.000511	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	6.62e-05	0.000511	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYP2E1—Parkinson's disease	6.54e-05	0.000504	CbGpPWpGaD
Dobutamine—CA2—Metabolism—NQO1—Parkinson's disease	6.47e-05	0.000499	CbGpPWpGaD
Dobutamine—CA2—Metabolism—TH—Parkinson's disease	6.37e-05	0.000491	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	6.29e-05	0.000485	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	6.2e-05	0.000479	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—MTHFR—Parkinson's disease	6.18e-05	0.000477	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—APOE—Parkinson's disease	6.17e-05	0.000476	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	6.15e-05	0.000475	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	6.13e-05	0.000472	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CYCS—Parkinson's disease	6.12e-05	0.000472	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	6.07e-05	0.000468	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	5.99e-05	0.000462	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP2D6—Parkinson's disease	5.99e-05	0.000462	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.89e-05	0.000454	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CTGF—Parkinson's disease	5.88e-05	0.000454	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.76e-05	0.000444	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—APOE—Parkinson's disease	5.76e-05	0.000444	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYP2E1—Parkinson's disease	5.48e-05	0.000423	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	5.42e-05	0.000418	CbGpPWpGaD
Dobutamine—CA2—Metabolism—COMT—Parkinson's disease	5.42e-05	0.000418	CbGpPWpGaD
Dobutamine—COMT—Metabolism—NQO1—Parkinson's disease	5.42e-05	0.000418	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTP1—Parkinson's disease	5.39e-05	0.000416	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MAOA—Parkinson's disease	5.38e-05	0.000415	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	5.36e-05	0.000413	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	5.35e-05	0.000413	CbGpPWpGaD
Dobutamine—COMT—Metabolism—TH—Parkinson's disease	5.34e-05	0.000412	CbGpPWpGaD
Dobutamine—CA2—Metabolism—HMOX1—Parkinson's disease	5.32e-05	0.00041	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	5.3e-05	0.000409	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—INS—Parkinson's disease	5.27e-05	0.000406	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	5.24e-05	0.000404	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	5.23e-05	0.000404	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	5.14e-05	0.000397	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CYCS—Parkinson's disease	5.13e-05	0.000395	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	5.11e-05	0.000394	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ABCB1—Parkinson's disease	5.1e-05	0.000394	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	5.03e-05	0.000388	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	5.03e-05	0.000388	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	5e-05	0.000386	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GSTM1—Parkinson's disease	4.96e-05	0.000382	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	4.94e-05	0.000381	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	4.92e-05	0.00038	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—INS—Parkinson's disease	4.92e-05	0.000379	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	4.83e-05	0.000372	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	4.78e-05	0.000369	CbGpPWpGaD
Dobutamine—CA2—Metabolism—GPX1—Parkinson's disease	4.75e-05	0.000366	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	4.68e-05	0.000361	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	4.64e-05	0.000358	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	4.61e-05	0.000356	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	4.57e-05	0.000353	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	4.54e-05	0.00035	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTP1—Parkinson's disease	4.52e-05	0.000349	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	4.51e-05	0.000348	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MAOA—Parkinson's disease	4.51e-05	0.000348	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	4.48e-05	0.000346	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	4.47e-05	0.000345	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.46e-05	0.000344	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HMOX1—Parkinson's disease	4.46e-05	0.000344	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	4.39e-05	0.000338	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MTHFR—Parkinson's disease	4.38e-05	0.000338	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PENK—Parkinson's disease	4.37e-05	0.000337	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAG—Parkinson's disease	4.37e-05	0.000337	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	4.37e-05	0.000337	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	4.34e-05	0.000335	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	4.32e-05	0.000334	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	4.32e-05	0.000334	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ABCB1—Parkinson's disease	4.28e-05	0.00033	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PENK—Parkinson's disease	4.28e-05	0.00033	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAG—Parkinson's disease	4.28e-05	0.00033	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	4.25e-05	0.000328	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	4.23e-05	0.000326	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	4.23e-05	0.000326	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GSTM1—Parkinson's disease	4.15e-05	0.00032	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APOE—Parkinson's disease	4.08e-05	0.000314	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	4.05e-05	0.000313	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	4e-05	0.000308	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GPX1—Parkinson's disease	3.98e-05	0.000307	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	3.97e-05	0.000306	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	3.93e-05	0.000303	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	3.93e-05	0.000303	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	3.91e-05	0.000302	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	3.84e-05	0.000296	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	3.84e-05	0.000296	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	3.76e-05	0.00029	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	3.72e-05	0.000287	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	3.68e-05	0.000284	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MTHFR—Parkinson's disease	3.67e-05	0.000283	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	3.64e-05	0.00028	CbGpPWpGaD
Dobutamine—CA2—Metabolism—INS—Parkinson's disease	3.48e-05	0.000269	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	3.46e-05	0.000267	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOE—Parkinson's disease	3.42e-05	0.000264	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	3.39e-05	0.000261	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	3.26e-05	0.000251	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	3.19e-05	0.000246	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	3.16e-05	0.000244	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	3.14e-05	0.000242	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	3.09e-05	0.000238	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	3.08e-05	0.000237	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.03e-05	0.000234	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	2.96e-05	0.000228	CbGpPWpGaD
Dobutamine—COMT—Metabolism—INS—Parkinson's disease	2.92e-05	0.000225	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—INSR—Parkinson's disease	2.92e-05	0.000225	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—INSR—Parkinson's disease	2.85e-05	0.00022	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGB—Parkinson's disease	2.76e-05	0.000213	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	2.75e-05	0.000212	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	2.74e-05	0.000211	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	2.7e-05	0.000208	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGB—Parkinson's disease	2.7e-05	0.000208	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	2.69e-05	0.000207	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	2.68e-05	0.000207	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	2.65e-05	0.000204	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	2.64e-05	0.000204	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	2.59e-05	0.0002	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	2.56e-05	0.000198	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	2.51e-05	0.000194	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	2.4e-05	0.000185	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	2.34e-05	0.000181	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	2.32e-05	0.000179	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	2.32e-05	0.000179	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	2.27e-05	0.000175	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	2.27e-05	0.000175	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	1.94e-05	0.00015	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	1.9e-05	0.000147	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	1.88e-05	0.000145	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	1.86e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	1.84e-05	0.000142	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	1.82e-05	0.00014	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NGF—Parkinson's disease	1.71e-05	0.000132	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NGF—Parkinson's disease	1.67e-05	0.000129	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	1.62e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	1.59e-05	0.000123	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOE—Parkinson's disease	1.51e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOE—Parkinson's disease	1.48e-05	0.000114	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—INS—Parkinson's disease	1.29e-05	9.95e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—INS—Parkinson's disease	1.26e-05	9.74e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	9.61e-06	7.41e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	9.54e-06	7.36e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	9.4e-06	7.25e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	9.34e-06	7.2e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	8.83e-06	6.81e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	8.64e-06	6.66e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6—Parkinson's disease	5.64e-06	4.35e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6—Parkinson's disease	5.52e-06	4.25e-05	CbGpPWpGaD
